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Abstract
Background: Based on the recently sequenced gene coding for the Trypanosoma evansi (T. evansi)
RoTat 1.2 Variable Surface Glycoprotein (VSG), a primer pair was designed targeting the DNA
region lacking homology to other known VSG genes. A total of 39 different trypanosome stocks
were tested using the RoTat 1.2 based Polymerase Chain Reaction (PCR).
Results: This PCR yielded a 205 bp product in all T. evansi and in seven out of nine T. equiperdum
strains tested. This product was not detected in the DNA from T. b. brucei, T. b. gambiense, T. b.
rhodesiense, T. congolense, T. vivax and T. theileri parasites. The Rotat 1.2 PCR detects as few as 10
trypanosomes per reaction with purified DNA from blood samples, i.e. 50 trypanosomes/ml.
Conclusion: PCR amplification of the RoTat 1.2 VSG gene is a specific marker for T. evansi strains,
except T. evansi type B, and is especially useful in dyskinetoplastic strains where kDNA based
markers may fail to amplify. Furthermore, our data support previous suggestions that some T. evansi
stocks have been previously misclassified as T. equiperdum.
Background
Surra is an animal disease occurring in Africa, Asia and
Latin America, caused by Trypanosoma evansi.  T. evansi
belongs to the subgenus Trypanozoon, together with T.
equiperdum and T. brucei. The parasite can infect different
host species and is mechanically transmitted by different
biting flies such as Tabanidae and Stomoxys as well as by
vampire bats such as Desmodus rotondus [1]. Camels and
horses are very susceptible to the infection and death can
occur within weeks or months. Moreover, T. evansi infec-
tions of cattle and buffaloes usually lead to a pronounced
immunosuppression resulting in an increased susceptibil-
ity to other opportunistic diseases such as Pasteurella and
anthrax [2].
Diagnosis of a T. evansi infection usually starts with clini-
cal symptoms or the detection of antibodies to T. evansi.
Conclusive evidence of T. evansi infection, however, relies
on detection of the parasite in the blood or tissue fluids of
infected animals. Unfortunately, parasitological tech-
niques cannot always detect ongoing infections as the
level of parasitaemia is often low and fluctuating, particu-
larly during the chronic stage of the disease [3].
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As an alternative to parasitological tests, DNA detection
based on PCR has been proposed. Trypanozoon specific
primers have been designed previously: TBR primers
which target a 177 bp repeat [4], pMUTEC primers target-
ing a retrotransposon [5] and ORPHON primers which
target the spliced leader sequence [6]. Most of them have
been tested on cattle [7,8], water buffaloes [9] or goats
[10]. PCR tests for diagnosis of T. congolense and T. vivax
infections exist as well [11]. The development of a PCR
test that would be able to differentiate between the differ-
ent members of the Trypanozoon subgenus still remains a
challenging issue. For T. evansi infections, the only specific
test available so far is based on the detection of a kineto-
plast DNA sequence [12,13]. However, the existence of
dyskinetoplastic trypanosomes such as T. evansi RoTat 5.1
[14] and E152 [12] casts doubt about the diagnostic
potential of such tests to detect all infections caused by T.
evansi parasites. Recently, Ventura et al. [15] developed a
PCR (PCR-Te664) for the detection of T. evansi based on a
Random Amplified Polymorphic DNA (RAPD) fragment.
The taxon specificity of this PCR remains uncertain since
it was only tested on nine T. evansi strains, one T. equiper-
dum, two T. b. gambiense and one T. b. rhodesiense. Follow-
ing evidence that the variable epitope of RoTat 1.2 VSG is
expressed by all T. evansi strains tested so far [16], and that
the gene encoding RoTat 1.2 VSG is present in all T. evansi
but not in T. brucei isolates [17], we designed primers
derived from the sequence of this VSG cDNA. In this arti-
cle we will present and discuss the results obtained with
these primers and compare them to the results we
obtained using the PCR-Te664.
Results
PCR RoTat 1.2 : taxon specificity
The 39 different trypanosome stocks used in this study are
listed in Table 1 [see Additional file 1]. They were derived
from a wide range of hosts and from distinct geographical
locations. In all PCR runs, RoTat 1.2 DNA was used as a
positive control. As shown in Figure 1, the RoTat 1.2 PCR
yielded a 205 bp amplicon in the positive control (lane 1)
as well as in all other T. evansi populations (lanes 3–8).
Moreover, the same fragment was found in seven out of
the nine T. equiperdum populations tested. The T. equiper-
dum BoTat 1.1 was PCR negative (lane 10), while the T.
equiperdum OVI strain yielded a PCR product shorter than
205 bp (lane 11) probably due to mispriming. All other
tested trypanosome populations, including six T. b. brucei,
eight T. b. gambiense, five T. b. rhodesiense, two T. congo-
lense, one T. vivax and one T. theileri, were negative. (lanes
18–40). As a negative control, a PCR-mix without tem-
plate DNA was included (lane 2). Sequencing of the posi-
tive samples revealed that all amplicon were identical
(data not shown). The weak band in OVI did not yield suf-
ficient material to enable sequencing.
PCR RoTat 1.2 : analytical sensitivity
A tenfold dilution series (105 trypanosomes down to 1
trypanosome per 200 µl sample) of RoTat 1.2 trypano-
somes in mouse blood was prepared to determine the
analytical sensitivity of the PCR. As shown in figure 2, the
PCR was able to detect as few as 10 trypanosomes per PCR
reaction, which corresponds with a lower detection limit
of 50 trypanosomes per ml. In principle, this limit can still
PCR specificity results for the different Trypanosoma (T.) spe- cies and subspecies in this study Figure 1
PCR specificity results for the different Trypanosoma 
(T.) species and subspecies in this study. Lane 1 pos. 
control RoTat 1.2, Lane 2 neg. control, Lanes 3–8 (T. evansi) 
are, respectively, AnTat 3.1, STIB 816, Zagora I.17, Colom-
bia, Merzouga 56, CAN 86 K; Lanes 9–17 (T. equiperdum) are, 
respectively, AnTat 4.1, BoTat 1.1, OVI, STIB 818, Alfort, 
Hamburg, SVP, Am. Strain, Can. Strain ; Lanes 18–23 (T.b.bru-
cei) are, AnTat 1.8, AnTat 2.2, AnTat 5.5, KETRI 2494, TSW 
196, STIB 348; Lanes 24–31 (T.b.gambiense) are, respectively, 
AnTat 9.1, AnTat 11.6, AnTat 22.1, NABE, SEKA, ABBA, 
LIGO, LiTat 1.6; Lanes 32–36 (T.b. rhodesiense) are STIB 884, 
STIB 850, AnTat 25.1/S, Etat 1.2/S, AnTat 12.1/S ; Lanes 37–
38 (T. congolense) are IL1180, TRT 17; Lane 39 (T. vivax) is 
ILRAD 700 and Lane 40 (T. theileri) is MELSELE ; Lanes M 100 
bp molecular marker (MBI Fermentas, Germany).Kinetoplastid Biology and Disease 2004, 3:3 http://www.kinetoplastids.com/content/3/1/3
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be lowered if a blood sample of 200 µl extracted with the
QIAamp DNA mini kit is eluted in less than 200 µl.
PCR-Te664 : taxon specificity
To evaluate the RoTat 1.2 diagnostic system alongside
other published methods, we compared our method to
the PCR-Te664 method as published by Ventura et al. [15]
using the same trypanosome stocks. The PCR-Te664
method yielded the expected amplicon in all seven T.
evansi strains and in seven out of nine T. equiperdum. As
with the RoTat 1.2 PCR only T. equiperdum strains OVI and
BoTat 1.1 remained negative. Unexpectedly, four out of
six T. b. brucei (AnTat 2.2, AnTat 5.2, TSW 196 and KETRI
2494) and two T. b. gambiense type II strains (ABBA and
LIGO) tested positive in this PCR (data not shown).
Discussion
This study was initiated to develop a specific PCR test that
would be able to distinguish T. evansi from the other
members of the Trypanozoon subgenus. The study is an
extension of the initial observation that the RoTat 1.2 VSG
gene only is found in T. evansi and not in T. brucei strains
[17]. This study mainly focused on the presence and
expression of the RoTat 1.2 VSG gene in T. evansi rather
than the use of this VSG in diagnosis of Salivarian
trypanosomes.
Previously, other research groups have used VSG genes as
target sequences for PCR detection of T.b. gambiense infec-
tions (sleeping sickness). In these studies, five different
primers derived from VSG genes, AnTat 11.17, LiTat 1.3,
117, 2 K and U2 were used in PCR screening of different
trypanosome populations, originating from distinct geo-
graphical locations [18-20]. AnTat 11.17 based PCR tests
were capable of distinguishing T.b. gambiense from T.b.
brucei  parasites from most foci of sleeping sickness in
countries such as Nigeria, Cameroon, Côte d'Ivoire, R. P.
Congo/Brazza. and Sudan. However, populations origi-
nating from the Moyo focus in North-west Uganda and
from Cameroon were shown to be negative in AnTat
11.17 and in LiTat 1.3 (2 K) PCRs respectively. According
to Bromidge et al. [18], this might be due to antigenic var-
iation and genetic evolution of the VSG genes. On the
other hand, the presence of 117 and U2 genes was shown
to be a common feature among all T. brucei populations
tested. In T. evansi, a similar phenomenon may occur in
certain Kenyan isolates. A recent study by Ngaira et al. [21]
pointed out that some T. evansi stocks in the Isiolo district
in Kenya seem to lack the Rotat 1.2 VSG gene. It is
believed that these stabilates belong to the T. evansi type B
group. So far, this type of T. evansi has only been observed
in this specific region in Kenya [22,23]. To our knowledge,
all other T. evansi isolated elsewhere, are from the classical
T. evansi type A group. Thus, we assume that, except for
these few Kenyan strains belonging to the type B group,
our PCR is specific for T. evansi.
Compared to the PCR-Te664 presented by Ventura et al.
[15], the PCR RoTat 1.2 seems to have a higher taxon spe-
cificity, since no reaction with T. b. brucei, nor with T. b.
gambiense  type II was observed. However, regarding T.
equiperdum, both PCR test positive for the same seven T.
equiperdum strains and are both negative for the BoTat 1.1
and OVI strains. Since the RAPD fragment (AF397194)
shares no homology with the Rotat 1.2 VSG gene
(AF317914) and is not found within the expression site of
trypanosomes, both sequences can be considered as inde-
pendent molecular markers. Based on the observations
with both markers, it appears that on the genomic level
the Botat 1.1 and the OVI strains are different from the
other T. equiperdum and T. evansi strains. The observed
analytical sensitivity with the RoTat 1.2 PCR is compara-
ble to what was reported for the Te664 PCR (25 cells per
reaction) [15].
The presence of a RoTat 1.2 specific DNA sequence in
some T. equiperdum strains corresponds with the serologi-
cal evidence that rabbits experimentally infected with
these strains develop RoTat 1.2 specific lytic antibodies
within 30 days post infection [24]. In contrast, rabbits
infected with the BoTat 1.1 clone and the OVI strain,
which are negative in the present PCR, did not produce
specific antibodies to the RoTat 1.2 clone when tested in
immune trypanolysis. This might be explained by the loss
of the RoTat 1.2 gene in the OVI and the BoTat 1.1 strain.
Analytical sensitivity of the RoTat 1.2 PCR Figure 2
Analytical sensitivity of the RoTat 1.2 PCR. Lanes M 
100 bp molecular marker (MBI Fermentas, Germany); lane 1: 
105 trypanosomes, lane 2: 104 trypanosomes, lane 3: 103 trpy-
anosomes, lane 4: 102 trypanosomes, lane 5: 10 trypano-
somes, lane 6: 1 trypanosome, lane 7: 0.1 trypanosome, lane 
8: negative control.Kinetoplastid Biology and Disease 2004, 3:3 http://www.kinetoplastids.com/content/3/1/3
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It is also possible that there has been a sequence drift at
the sites where these primers could bind. However, we
hypothesize that RoTat 1.2 VSG truly is T. evansi specific
and that RoTat 1.2 PCR positive T. equiperdum strains are
actually T. evansi and not T. equiperdum. Indeed, in a pre-
vious molecular characterization study using Random
Amplified Polymorphic DNA (RAPD) and the Multiplex-
endonuclease Genotyping Approach (MEGA) it appeared
that the T. equiperdum collection is not as homogenous as
previously believed and that the generally followed con-
cept that T. equiperdum is very closely related to T. evansi
and more distant from T. b. brucei, seems incorrect. From
the cluster analysis on the available strains, it appeared
that only two clusters can be identified: a homogeneous T.
evansi/T. equiperdum cluster and a more heterogeneous T.
b. brucei/T. equiperdum cluster [25]. Interestingly, all
strains of that homogeneous T. evansi/T. equiperdum clus-
ter are all PCR RoTat 1.2 VSG positive while the strains
found in the more heterogeneous T. b. brucei/T. equiper-
dum cluster, in casu BoTat 1.1 and OVI are PCR RoTat 1.2
VSG negative.
Conclusions
PCR amplification of the RoTat 1.2 VSG gene is a specific
marker for T. evansi strains, except T. evansi type B, and is
especially useful in dyskinetoplastic strains where kDNA
based markers may fail to amplify. Furthermore, our data
support previous suggestions that some T. evansi stocks
have been previously misclassified as T. equiperdum.
Methods
Trypanosome populations
A total of 39 different trypanosome populations were
used in this study. They belong to 39 stocks and six spe-
cies, isolated from a variety of host species at distinct geo-
graphical locations (Table 1 [see Additional file 1]). Only
three T. equiperdum strains, BoTat 1.1, OVI and STIB 818
are well documented, i.e. known origin and host. The
other six are putative T. equiperdum, based on publications
or on their use as reference strains in different national
dourine reference laboratories [26-30].
Preparation of trypanosome DNA
Procyclic trypanosome populations were grown in vitro in
Cunningham's medium [31] and in the Kit for In Vitro
Isolation (KIVI) [32]. Pure procyclic trypanosomes were
obtained by repeated centrifugation (20 min., 2000 g)
and sediment washes with Phosphate Glucose Sacharose
buffer (PGS) (38 mM Na2HPO4.2H20, 2 mM NaHPO4, 80
mM glucose, 100 mM sacharose, pH 8.0). Bloodstream
form trypanosomes were expanded in mice and rats and
were purified from the blood by di-ethyl-amino-ethyl
(DEAE) chromatography [33], followed by repeated cen-
trifugation (20 min., 2000 g) and sediment washes with
Phosphate Buffered Saline Glucose (PSG) (38 mM
Na2HPO4.2H20, 2 mM NaHPO4, 80 mM glucose, 29 mM
NaCl, pH 8.0). Trypanosome sediments were subse-
quently stored at -80°C.
Twenty µl of trypanosome sediment (approximately 2.107
cells) were resuspended in 200 µl of Phosphate Buffered
Saline (PBS) (8.1 mM Na2HPO4.2H20, 1.4 mM NaHPO4,
140 mM NaCl, pH 7.4) and the trypanosome DNA was
extracted using the commercially available QIAamp DNA
mini kit (Westburg, Leusden, The Netherlands), resulting
in pure DNA in 200 µl of TE buffer. The typical yield of
DNA extracted from a 20 µl pellet was 150 ng/µl or 30 µg
total DNA. The extracts obtained were diluted 200 times
in water and divided into aliquots of 2 ml in microcentri-
fuge tubes for storage at -20°C.
For trypanosome dilution series, 180 µl of each
heparinized blood sample were mixed with an equal vol-
ume of the Qiagen AS-1 storage buffer and subsequently
extracted using the QIAamp DNA blood mini kit (West-
burg, Leusden, The Netherlands) resulting in 200 µl of
extracted DNA in Millipore water. Manipulation was per-
formed according to the manufacturer's instructions.
PCR RoTat 1.2
Primers were derived from the RoTat 1.2 VSG sequence
(AF317914), recently cloned and sequenced by Urakawa
et al. [17]. Using DNA sequence homology search pro-
grams to interrogate databases at TIGR (The Institute for
Genomic Research) and GenBank, primer sequences were
identified within the region (608–812 bp) lacking homol-
ogy with any other known VSG sequence present in the
databases. Primer sequences (in 5'-3' direction) and
annealing temperatures were as follows: RoTat 1.2 For-
ward GCG GGG TGT TTA AAG CAA TA, Tann. 59°C and
RoTat 1.2 Reverse ATT AGT GCT GCG TGT GTT CG, Tann.
59°C.
Twenty µl of extracted DNA were mixed with 30 µl of a
PCR-mix containing: 1 U Taq DNA recombinant polymer-
ase (Promega, UK), PCR buffer (Promega, UK), 2.5 mM
MgCl2 (Promega, UK), 200 µM of each of the four dNTPs
(Roche, Mannheim, Germany) and 0.8 µM of each primer
(Gibco BRL, UK).
All amplifications were carried out in a Biometra® Trio-
block thermocycler. Cycling conditions were as follows:
denaturation for 4 min. at 94°C, followed by 40 amplifi-
cation cycles of 1 min. denaturation at 94°C, 1 min.
primer-template annealing at 59°C and 1 min. polymeri-
zation at 72°C. A final elongation step was carried out for
5 min. at 72°C.
Twenty µl of the PCR product and ten µl of a 100 bp size
marker (MBI Fermentas, Germany) were subjected to elec-Kinetoplastid Biology and Disease 2004, 3:3 http://www.kinetoplastids.com/content/3/1/3
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trophoresis in a 2 % agarose gel (25 min. at 100 V). Gels
were stained with ethidium bromide (0.5 µg/ml) (Sigma,
USA) and analyzed on an Imagemaster Video Detection
System (Pharmacia, UK).
PCR Te-664
PCR on purified DNA samples was performed using prim-
ers and PCR conditions according to Ventura et al. [15].
Only the Taq  DNA polymerase was purchased from
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